Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 15 November 2007. doi:10.1136/adc.2007.121053
Archives of Disease in Childhood - Fetal and Neonatal Edition 2008;93:F135-F139
Copyright © 2008 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health.

ORIGINAL ARTICLES

Attempt to improve transcutaneous bilirubinometry: a double-blind study of Medick BiliMed versus Respironics BiliCheck

D De Luca, E Zecca, M Corsello, E Tiberi, C Semeraro and C Romagnoli

Department of Paediatrics, Neonatology Division, University Hospital "A Gemelli", Catholic University of the Sacred Heart, Rome, Italy

Correspondence to:
Dr D De Luca, Divisione di Neonatologia, Departimento di Scienze Pediatriche, Policlinico Universitario "A.Gemelli", L.go Agostino Gemelli 8, 00168 Roma, Italia; dm.deluca{at}fastwebnet.it

Objectives: To compare the accuracy of a new transcutaneous bilirubinometer, BiliMed (Medick SA, Paris, France) with BiliCheck (Respironics, Marietta, GA, USA), a widely available instrument, and with total serum bilirubin measurement.

Design: A prospective double-blind study comparing the two devices was carried out. 686 healthy newborns needing measurement of their bilirubin were enrolled over a 4-month period. Serum and transcutaneous bilirubin measurements were taken with both devices within 15 minutes. The order of use of the instruments was randomised.

Setting: Well-baby nursery ward in a university hospital, tertiary referral centre.

Results: The linear regression analysis showed a better correlation between BiliCheck and serum bilirubin (r = 0.75) than between BiliMed and serum bilirubin (r = 0.45). BiliCheck variability (±2 SD of the mean bias from serum bilirubin) was within –87.2 to 63.3 µmol/l, while BiliMed variability was within –97.5 to 121.4 µmol/l. The receiver operating characteristic analysis (for serum bilirubin levels >205.2 µmol/l or >239.4 µmol/l) showed significantly higher areas under the curve for BiliCheck than those for BiliMed (p<0.001).

Conclusions: Despite the potential practical advantages of BiliMed, its reduced diagnostic accuracy in comparison with BiliCheck does not justify its use in clinical practice.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • El-Beshbishi, S. N., Shattuck, K. E., Mohammad, A. A., Petersen, J. R. (2009). Hyperbilirubinemia and Transcutaneous Bilirubinometry. Clin. Chem. 55: 1280-1287 [Abstract] [Full Text]  
  • Thomson, J, Culley, V, Monfrinoli, A, Sinha, A (2008). Transcutaneous bilirubinometers and ethnicity. Arch. Dis. Child. Fetal Neonatal Ed. 93: F474-F474 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest from ADC

 

ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

BMJ Careers - Latest Paediatrics and Paediatric Surgery Jobs

Paediatrics and Paediatric Surgery Jobs